These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 10601978)
21. Loss of an estrogen receptor isoform (ER alpha delta 3) in breast cancer and the consequences of its reexpression: interference with estrogen-stimulated properties of malignant transformation. Erenburg I; Schachter B; Mira y Lopez R; Ossowski L Mol Endocrinol; 1997 Dec; 11(13):2004-15. PubMed ID: 9415404 [TBL] [Abstract][Full Text] [Related]
22. Effects of selenite on estrogen receptor-alpha expression and activity in MCF-7 breast cancer cells. Stoica A; Pentecost E; Martin MB J Cell Biochem; 2000 Aug; 79(2):282-92. PubMed ID: 10967555 [TBL] [Abstract][Full Text] [Related]
23. Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells. Lim JT; Joe AK; Suzui M; Shimizu M; Masuda M; Weinstein IB Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3478-84. PubMed ID: 16740773 [TBL] [Abstract][Full Text] [Related]
24. Expression of estrogen receptor beta messenger RNA variant in breast cancer. Vladusic EA; Hornby AE; Guerra-Vladusic FK; Lupu R Cancer Res; 1998 Jan; 58(2):210-4. PubMed ID: 9443393 [TBL] [Abstract][Full Text] [Related]
25. Resveratrol acts as an estrogen receptor (ER) agonist in breast cancer cells stably transfected with ER alpha. Levenson AS; Gehm BD; Pearce ST; Horiguchi J; Simons LA; Ward JE; Jameson JL; Jordan VC Int J Cancer; 2003 May; 104(5):587-96. PubMed ID: 12594813 [TBL] [Abstract][Full Text] [Related]
26. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha. Kinoshita Y; Chen S Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940 [TBL] [Abstract][Full Text] [Related]
27. Relationship of clone 4 estrogen receptor variant messenger RNA expression to some known prognostic variables in human breast cancer. Murphy LC; Hilsenbeck SG; Dotzlaw H; Fuqua SA Clin Cancer Res; 1995 Feb; 1(2):155-9. PubMed ID: 9815968 [TBL] [Abstract][Full Text] [Related]
28. Role of insulin-like growth factor-I in regulating estrogen receptor-alpha gene expression. Stoica A; Saceda M; Fakhro A; Joyner M; Martin MB J Cell Biochem; 2000 Jan; 76(4):605-14. PubMed ID: 10653980 [TBL] [Abstract][Full Text] [Related]
29. Oestrogen receptor-alpha variant mRNA expression in primary human breast tumours and matched lymph node metastases. Leygue E; Hall RE; Dotzlaw H; Watson PH; Murphy LC Br J Cancer; 1999 Feb; 79(5-6):978-83. PubMed ID: 10070900 [TBL] [Abstract][Full Text] [Related]
30. Estrogen receptor variants in normal human mammary tissue. Leygue ER; Watson PH; Murphy LC J Natl Cancer Inst; 1996 Mar; 88(5):284-90. PubMed ID: 8614007 [TBL] [Abstract][Full Text] [Related]
32. Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells. Balasenthil S; Barnes CJ; Rayala SK; Kumar R FEBS Lett; 2004 Jun; 567(2-3):243-7. PubMed ID: 15178330 [TBL] [Abstract][Full Text] [Related]
33. Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Fuqua SA; Fitzgerald SD; Chamness GC; Tandon AK; McDonnell DP; Nawaz Z; O'Malley BW; McGuire WL Cancer Res; 1991 Jan; 51(1):105-9. PubMed ID: 1988075 [TBL] [Abstract][Full Text] [Related]
34. Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Maggiolini M; Bonofiglio D; Marsico S; Panno ML; Cenni B; Picard D; Andò S Mol Pharmacol; 2001 Sep; 60(3):595-602. PubMed ID: 11502892 [TBL] [Abstract][Full Text] [Related]
35. Identification of twenty alternatively spliced estrogen receptor alpha mRNAs in breast cancer cell lines and tumors using splice targeted primer approach. Poola I; Koduri S; Chatra S; Clarke R J Steroid Biochem Mol Biol; 2000 Apr; 72(5):249-58. PubMed ID: 10822014 [TBL] [Abstract][Full Text] [Related]
36. The N-terminal of the estrogen receptor (ERalpha) mediates transcriptional cross-talk with the retinoic acid receptor in human breast cancer cells. Rousseau C; Pettersson F; Couture MC; Paquin A; Galipeau J; Mader S; Miller WH J Steroid Biochem Mol Biol; 2003 Jul; 86(1):1-14. PubMed ID: 12943740 [TBL] [Abstract][Full Text] [Related]
37. Novel mutations in the estrogen receptor messenger RNA in human breast cancers. Murphy LC; Wang M; Coutt A; Dotzlaw H J Clin Endocrinol Metab; 1996 Apr; 81(4):1420-7. PubMed ID: 8636345 [TBL] [Abstract][Full Text] [Related]
38. Altered expression of estrogen receptor-alpha variant messenger RNAs between adjacent normal breast and breast tumor tissues. Leygue E; Dotzlaw H; Watson PH; Murphy LC Breast Cancer Res; 2000; 2(1):64-72. PubMed ID: 11400682 [TBL] [Abstract][Full Text] [Related]
39. Prevalence of estrogen receptor variant messenger RNAs in human breast cancer. Leygue E; Huang A; Murphy LC; Watson PH Cancer Res; 1996 Oct; 56(19):4324-7. PubMed ID: 8813116 [TBL] [Abstract][Full Text] [Related]
40. Melatonin modulation of estrogen-regulated proteins, growth factors, and proto-oncogenes in human breast cancer. Molis TM; Spriggs LL; Jupiter Y; Hill SM J Pineal Res; 1995 Mar; 18(2):93-103. PubMed ID: 7629697 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]